This is a chemistry explainer, written under the compliance bound set for its cluster: composition and mechanism only, from published chemistry and labelled facts. It makes no claim about what either form does to a reader and draws no comparison of merit between the forms.
It sits under what is inside a nicotine pouch. Written for adult nicotine users: 18 and over in Europe and the UK, 21 and over in the US.
What is freebase nicotine, chemically?
Nicotine in its plain molecular state carries nitrogens that can accept a proton. Unprotonated, the molecule is a base, and that state is what the industry calls freebase. The term is older than pouches: it distinguishes the base form of a compound from its salt forms. It is the reference state from which salts are made and to which, under the right pH conditions, a proportion of nicotine returns. The physicochemical literature on oral pouches treats the unprotonated fraction as a formulation property that makers set and laboratories measure.
How is a nicotine salt made?
By reacting the base with an acid. A February 2020 briefing published by Physicians for a Smoke-Free Canada puts it in one line: exposing freebase nicotine to an acid converts the nicotine to a salted form, in which the nicotine molecule picks up a hydrogen proton. The acids named in that summary are organic acids, benzoic acid, lactic acid and levulinic acid among them. The salt is a different chemical substance from the base, with its own stability and solubility properties, which is why formulators choose between forms.
| Fact | Freebase nicotine | Nicotine salt |
|---|---|---|
| Chemical state | Unprotonated: the molecule in its plain base state | Protonated: the base after an acid has donated a proton to it |
| How it is formed | The reference state from which salts are made | By reacting the base with an acid; benzoic, lactic and levulinic acids are named in the cited briefing |
| Relation to pH | Its share in a formulation is set by pH; published studies measure the unprotonated fraction | In an aqueous formulation, pH influences the balance between protonated and unprotonated nicotine; the starting form alone does not determine the final pH |
| Documented pouch forms | The state a cited patent describes forming in saliva from its salt form | Nicotine bitartrate is a salt. Nicotine polacrilex is a separate ion-exchange resin complex. Both appear in a European pouch composition patent's worked examples |
| Stability as described in formulation documents | Not the form the cited patent stores in the powder | US9161908B2 describes its salt form as stable in the dry powder until saliva dissolves it |
Which forms do pouches actually use?
The documented pouch forms are salts and resin complexes. EP4162927A1, a European patent for a nicotine pouch composition, describes worked compositions using nicotine bitartrate and nicotine polacrilex, filled into pouches as a powder with fibres, water, xylitol and sodium carbonate among the other components. Separately, US9161908B2 describes a formulation in which saliva dissolves a stored nicotine salt and pH-adjusting ingredients, allowing unprotonated nicotine to form. That is a manufacturer's description of its own formulation mechanism, quoted here as such.
Why does pH keep appearing in this subject?
Because pH is the dial that sets the balance between the two states in a finished product. Studies of oral nicotine pouches publish both numbers: total nicotine content, and the unprotonated, freebase share of it, which varies with the product's pH. A study in Tobacco Control measured total and unprotonated nicotine across new types of oral tobacco free nicotine products, and a physicochemical review in the journal Materials sets out the principles governing delivery from oral pouches in terms of pH and freebase fraction. For the reader, the practical consequence is the one the live strength coverage already draws: two pouches with the same labelled milligrams can be formulated differently, and pH is one of the variables. That comparison is worked through in why two pouches with the same mg feel different and the labelling side is in the strength guide.
Is one form the standard across all brands?
No single form is universal, and labels rarely make the form easy to find. Detailed form information often lives in regulatory filings, patents and laboratory studies rather than on the can, which is why this page sources its form claims to those documents instead of to brand marketing. How to read a nicotine pouch label explains what a can does and does not state.
FAQ
Is nicotine salt a different drug from freebase nicotine?
No. Both are the compound nicotine, in different protonation states. A salt is nicotine combined with an acid; the nicotine molecule itself is the same molecule in both forms.
Does the word salt mean table salt is involved?
No. Salt here is the chemistry term for the product of an acid reacting with a base. Sodium chloride plays no part in forming a nicotine salt, though salt appears separately as an ingredient in some pouch formulations, as what is inside a nicotine pouch records.
Which acids are used to make nicotine salts?
The briefing cited here names benzoic acid, lactic acid and levulinic acid as acids companies have used. The acid used in a specific product is a formulation detail from that product's documentation.
Do pouch labels state which form is used?
Usually not in plain terms. Labels state nicotine content; form details such as bitartrate or polacrilex appear in ingredient reporting, patents and studies. This page cites those document types for its form claims.
Why does the cited patent use a nicotine salt?
US9161908B2 describes storage stability as a reason for using a nicotine salt in its particular formulation: the salt form is described as stable in the dry powder until use. It does not establish why every manufacturer chooses a particular nicotine form.
Sources
- Tran et al., Total and unprotonated (freebase) nicotine content in new types of oral tobacco-free nicotine products, Tobacco Control via PubMed (measured total and unprotonated nicotine and pH in oral products): https://pubmed.ncbi.nlm.nih.gov/39542719/
- The Physicochemical Principles Governing Nicotine Delivery from Oral Nicotine Pouches, Materials (pH, freebase fraction and formulation): https://www.mdpi.com/1996-1944/19/20/4410
- US9161908B2, Pouch containing nicotine in free salt form, Google Patents (salt stable in powder until saliva contact; pH adjusting agent reaction described): https://patents.google.com/patent/US9161908B2/en
- Physicians for a Smoke-Free Canada, Pass the salt, February 2020 (acid converts freebase nicotine to a salt; benzoic, lactic and levulinic acids named): http://smoke-free.ca/wp-content/uploads/2020/04/Nicotine-Salts-1.pdf
- EP4162927, Nicotine pouch composition, European Patent Office publication server (worked examples built on nicotine bitartrate and nicotine polacrilex): https://data.epo.org/publication-server/rest/v1.2/patents/EP4162927NWA1/document.html